drugset / Trial / NCT06964061
Evaluate Efficacy, Safety, Tolerability and Biodegradation of PA5346 Ocular Implant in Patients With Open-Angle Glaucoma or Ocular Hypertension
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical study is to learn how effective and safe is a single administration of PA5346 Ocular Implant for the reduction of intraocular pressure in adult patients with open-angle glaucoma or ocular hypertension. It will also assess how long it takes for PA5346 Ocular Implant to dissolve in the eye.
Timeline
- Start
- 2025-06-10
- Primary completion
- 2027-02-15
- Completion
- 2027-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PA5436 Ocular Implant | Unknown | 115 ug | Other |